Possible role of DNA hypomethylation in the induction of SLE: Relationship of the transcription of human endogenous retroviruses

Clinical and Experimental Rheumatology

Volumn 21, Issue 6, 2003, Pages 733-738

  Ogasawara, H ^a   Okada, M ^a   Kaneko, H ^a   Hishikawa, T ^a   Sekigawa, I ^b   Hashimoto, H ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; MESSENGER RNA; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MONONUCLEAR CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS PATHOGENESIS; VIRUS TRANSCRIPTION;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA METHYLATION; DNA, VIRAL; ENDOGENOUS RETROVIRUSES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROBABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0348149025     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. URNOVITZ HB, MURPHY WH: Human endogenous retroviruses: Nature, occurrence, and clinical implications in human diseases. Clin Microbiol Rev 1996; 9: 72-99.
2. HERRMANN M, HAGENHOFER M, KALDEN Jr: Retroviruses and systemic lupus erythematosus. Immunol Rev 1996; 152: 145-56.
3. NAKAGAWA K, HARRISON LC: The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev 1996; 152: 193-236.
4. SEKIGAWA I, OGASAWARA H, KANEKO H, HISHIKAWA T, HASHIMOTO H: Retroviruses and autoimmunity. Intern Med 2001; 40: 80-6.
5. HISHIKAWA T, KANEKO H, SHIRASAWA T et al.: Detection of antibodies to recombinant gag protein derived from human endogenous retrovirus like sequence, clone 4-1, in autoimmune diseases. Viral Immunol 1997; 10: 137-47.
6. OGASAWARA H, KANEKO H, HISHIKAWA T et al.: Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen: with reference to the pathogenesis of systemic lupus erythematosus. Rheumatology 1999; 38: 1163-4.
7. OGASAWARA H, HISHIKAWA T, SEKIGAWA I, HASHIMOTO H, YAMAMOTO N, MARUYAMA M: Sequence analysis of human endogenous retrovirus clone 4-1 in systemic lupus erythematosus. Autoimmunity 2001; 33: 15-21.
8. OGASAWARA H, OKADA M, KANEKO H et al.: Quantitative comparison of human endogenous retrovirus mRNA between SLE and rheumatoid arthritis. Lupus 2001; 10: 517-8.
9. OGASAWARA H, NAITO T, KANEKO H et al.: Quantitative analyses of messenger RNA of human endogenous retrovirus in SLE patients. J Rheumatol 2001;28: 533-8.
10. OKADA M, OGASAWARA H, KANEKO H et al.: Role of DNA methylation in the transcription of human endogenous retrovirus: with reference to the pathogenesis of SLE. J Rheumatol 2002; 9: 1678-82.
11. CEDAR H: DNA methylation and gene activation. Cell 1988; 53: 3-4.
12. NAKAO M: Epigenetics: interaction of DNA methylation and chromatin. Gene 2001; 31: 25-31.
13. RICHARDSON B, YUNG R: Role of DNA methylation in the regulation of cell function. J Lab Clin Med 1999; 134: 333-40.
14. RICHARDSON B: Effect of an inhibitor of DNA methylation on T cells. II. 5-azacytidine induces self-reactivity in antigen-specific T4+ cells. Hum Immunol 1986; 17: 456-70.
15. RICHARDSON B, SCHEINBART L, STRAHLER J, GROSS L, HANASH S, JOHNSON M: Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990; 33: 1665-73.
16. RICHARDSON B, STRAHLER JR, PIVIROTTO S et al.: Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 1992; 35: 647-62.
17. QUDDUS J, JOHNSON KJ, GAVALCHIN J et al.: Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993; 92: 38-53.
18. YUNG RL, QUDDUS J, CHRIP CE, JOHNSON KJ, RICHARDSON BC: Mechanisms of drug-induced lupus. 1. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 1995; 154: 3025-35.
19. BESTOR T, LAUDANO A, MATTALIANO R, INGRAM V: Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. J Mol Biol 1988; 203: 971-83.
20. BESTOR TH: The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395-402.
21. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
22. SHIRAI T, OHTA K, KOHNO A et al.: Naturally occurring antibody response to DNA is associated with the response to retroviral gp70 in autoimmune New Zealand mice. Arthritis Rheum 1986; 29: 242-50.
23. WU J, ZHOU T, HE J, MOUNTZ JD: Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993; 178: 461-8.
24. DENG C, KAPLAN MJ, YANG J et al.: Decrease ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001; 44: 397-407.
25. KAPLAN MJ, ATTWOOD J, RICHARDSON BC, ARBOR A: DNA methylation and perforin expression in normal and lupus T cells [abstract]. Arthritis Rheum 2001; 44 (Suppl. 9): S895.
26. XU GL, BESTOR TH, BOURCHIS D et al.: Chromosome instability and immunodeficiency syndrome caused DNA methyltransferase gene. Nature 1999; 402: 187-90.
27. PRIGENT AF, FONLUPT P, DUBOIS M et al.: Activity of cyclic AMP phosphodiesterase and methyltransferases in leukocyte membranes from allergic patients. Clin Chim Acta 1984; 143: 225-33.
28. KUWABARA N, KONDO N, FUKUTOMI O, FUJII H, ORII T: Methylation pattern of I epsilon region in B cells stimulated with interleukin 4 and Epstein-Barr virus in patients with a high level of serum TgE. Eur J Immunogenet 1995; 22: 265-75.